abstract |
The present invention provides a composition comprising: a compound represented by chemical formula 1, an isomer thereof, or a pharmaceutically acceptable salt thereof; and a BTK inhibitor. The composition of the present invention exhibits an excellent lymphatic tumor treatment effect. |